<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Song Y</submitter><funding>Most | National Key Research and Development Program of China</funding><funding>Most | National Key Research and Development Program of China (973 Program)</funding><funding>National Natural Science Foundation of China</funding><funding>National Natural Science Foundation of China (NSFC)</funding><pagination>e0027321</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8552794</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(1)</volume><pubmed_abstract>The SARS-CoV-2 B.1.1.7 variant has increased sharply in numbers worldwide and is reported to be more contagious than the nonvariant. Little is known regarding the detailed clinical features of B.1.1.7 variant infection. Data on 74 COVID-19 cases from two outbreaks in two districts of Beijing, China were extracted from a cloud database, including 41 cases from Shunyi District (Shunyi B.1.470 group) and 33 from Daxing (Daxing B.1.1.7 group) from December 25, 2020 to January 17, 2021. We conducted a comparison of the clinical characteristics. Seven clinical indicators of the Daxing B.1.1.7 group were significantly higher than those of the Shunyi group, including the proportion with fever over 38°C, the levels of C-reactive protein (CRP), serum amyloid A (SAA), creatine kinase (CK), d-dimer (D</pubmed_abstract><journal>Microbiology spectrum</journal><pubmed_title>COVID-19 Cases from the First Local Outbreak of the SARS-CoV-2 B.1.1.7 Variant in China May Present More Serious Clinical Features: A Prospective, Comparative Cohort Study.</pubmed_title><pmcid>PMC8552794</pmcid><funding_grant_id>2020YFC0848300</funding_grant_id><funding_grant_id>2020YFC0846200</funding_grant_id><funding_grant_id>82072295</funding_grant_id><pubmed_authors>Xiang P</pubmed_authors><pubmed_authors>Liu L</pubmed_authors><pubmed_authors>Tan J</pubmed_authors><pubmed_authors>Tian D</pubmed_authors><pubmed_authors>Cui S</pubmed_authors><pubmed_authors>Zhao X</pubmed_authors><pubmed_authors>Zhang W</pubmed_authors><pubmed_authors>Zhang T</pubmed_authors><pubmed_authors>Chen Z</pubmed_authors><pubmed_authors>Ge Z</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Wan G</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Xu W</pubmed_authors><pubmed_authors>Song Y</pubmed_authors><pubmed_authors>Zhu S</pubmed_authors><pubmed_authors>Xu Y</pubmed_authors><pubmed_authors>Liu G</pubmed_authors></additional><is_claimable>false</is_claimable><name>COVID-19 Cases from the First Local Outbreak of the SARS-CoV-2 B.1.1.7 Variant in China May Present More Serious Clinical Features: A Prospective, Comparative Cohort Study.</name><description>The SARS-CoV-2 B.1.1.7 variant has increased sharply in numbers worldwide and is reported to be more contagious than the nonvariant. Little is known regarding the detailed clinical features of B.1.1.7 variant infection. Data on 74 COVID-19 cases from two outbreaks in two districts of Beijing, China were extracted from a cloud database, including 41 cases from Shunyi District (Shunyi B.1.470 group) and 33 from Daxing (Daxing B.1.1.7 group) from December 25, 2020 to January 17, 2021. We conducted a comparison of the clinical characteristics. Seven clinical indicators of the Daxing B.1.1.7 group were significantly higher than those of the Shunyi group, including the proportion with fever over 38°C, the levels of C-reactive protein (CRP), serum amyloid A (SAA), creatine kinase (CK), d-dimer (D</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2025-04-04T13:20:31.782Z</modification><creation>2022-02-11T12:40:28.47Z</creation></dates><accession>S-EPMC8552794</accession><cross_references><pubmed>34346755</pubmed><doi>10.1128/Spectrum.00273-21</doi></cross_references></HashMap>